杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2015/04/24 | 2,802 | 2,815 | 2,773 | 2,805 | -18 | -0.6% | 155,900 |
2015/04/23 | 2,872 | 2,872 | 2,817 | 2,823 | -30 | -1.1% | 145,400 |
2015/04/22 | 2,852 | 2,860 | 2,824 | 2,853 | +16 | +0.6% | 140,600 |
2015/04/21 | 2,795 | 2,840 | 2,795 | 2,837 | +61 | +2.2% | 126,400 |
2015/04/20 | 2,777 | 2,829 | 2,761 | 2,776 | -44 | -1.6% | 223,400 |
2015/04/17 | 2,874 | 2,884 | 2,818 | 2,820 | -36 | -1.3% | 247,700 |
2015/04/16 | 2,830 | 2,860 | 2,807 | 2,856 | -1 | ±0% | 177,800 |
2015/04/15 | 2,840 | 2,881 | 2,840 | 2,857 | -12 | -0.4% | 188,600 |
2015/04/14 | 2,857 | 2,879 | 2,844 | 2,869 | +1 | ±0% | 162,200 |
2015/04/13 | 2,900 | 2,900 | 2,838 | 2,868 | -55 | -1.9% | 212,300 |
2015/04/10 | 2,966 | 2,977 | 2,887 | 2,923 | -43 | -1.4% | 294,500 |
2015/04/09 | 2,933 | 2,971 | 2,918 | 2,966 | +54 | +1.9% | 263,300 |
2015/04/08 | 2,885 | 2,934 | 2,884 | 2,912 | +38 | +1.3% | 307,900 |
2015/04/07 | 2,880 | 2,880 | 2,835 | 2,874 | +2 | +0.1% | 252,000 |
2015/04/06 | 2,831 | 2,876 | 2,830 | 2,872 | +19 | +0.7% | 195,200 |
2015/04/03 | 2,872 | 2,887 | 2,815 | 2,853 | -19 | -0.7% | 143,400 |
2015/04/02 | 2,839 | 2,904 | 2,835 | 2,872 | +49 | +1.7% | 216,600 |
2015/04/01 | 2,843 | 2,843 | 2,787 | 2,823 | -51 | -1.8% | 226,200 |
2015/03/31 | 2,929 | 2,943 | 2,863 | 2,874 | -8 | -0.3% | 197,700 |
2015/03/30 | 2,878 | 2,897 | 2,842 | 2,882 | -9 | -0.3% | 205,900 |
2015/03/27 | 2,933 | 2,941 | 2,858 | 2,891 | -64 | -2.2% | 174,900 |
2015/03/26 | 2,970 | 2,970 | 2,915 | 2,955 | -21 | -0.7% | 148,800 |
2015/03/25 | 2,960 | 2,976 | 2,924 | 2,976 | -17 | -0.6% | 141,800 |
2015/03/24 | 2,931 | 2,999 | 2,931 | 2,993 | +33 | +1.1% | 161,100 |
2015/03/23 | 2,952 | 2,972 | 2,917 | 2,960 | +7 | +0.2% | 124,600 |
2015/03/20 | 2,950 | 2,957 | 2,900 | 2,953 | -14 | -0.5% | 301,100 |
2015/03/19 | 2,910 | 2,980 | 2,909 | 2,967 | +39 | +1.3% | 227,300 |
2015/03/18 | 2,922 | 2,953 | 2,913 | 2,928 | -6 | -0.2% | 189,600 |
2015/03/17 | 2,930 | 2,963 | 2,916 | 2,934 | +28 | +1% | 152,000 |
2015/03/16 | 2,924 | 2,940 | 2,882 | 2,906 | -39 | -1.3% | 227,300 |
2015/03/13 | 3,015 | 3,015 | 2,938 | 2,945 | -80 | -2.6% | 471,600 |
2015/03/12 | 2,930 | 3,040 | 2,919 | 3,025 | +125 | +4.3% | 400,200 |
2015/03/11 | 2,883 | 2,913 | 2,870 | 2,900 | +17 | +0.6% | 270,900 |
2015/03/10 | 2,898 | 2,910 | 2,856 | 2,883 | +10 | +0.3% | 185,200 |
2015/03/09 | 2,895 | 2,900 | 2,853 | 2,873 | -4 | -0.1% | 159,000 |
2015/03/06 | 2,837 | 2,898 | 2,837 | 2,877 | +26 | +0.9% | 201,800 |
2015/03/05 | 2,801 | 2,870 | 2,801 | 2,851 | +51 | +1.8% | 221,900 |
2015/03/04 | 2,800 | 2,831 | 2,788 | 2,800 | +18 | +0.6% | 236,100 |
2015/03/03 | 2,771 | 2,798 | 2,753 | 2,782 | +26 | +0.9% | 130,800 |
2015/03/02 | 2,668 | 2,764 | 2,668 | 2,756 | +79 | +3% | 233,900 |
2015/02/27 | 2,710 | 2,722 | 2,658 | 2,677 | -34 | -1.3% | 292,300 |
2015/02/26 | 2,699 | 2,735 | 2,653 | 2,711 | +17 | +0.6% | 191,100 |
2015/02/25 | 2,700 | 2,715 | 2,647 | 2,694 | -21 | -0.8% | 257,300 |
2015/02/24 | 2,738 | 2,738 | 2,657 | 2,715 | -23 | -0.8% | 209,700 |
2015/02/23 | 2,743 | 2,748 | 2,692 | 2,738 | +1 | ±0% | 197,800 |
2015/02/20 | 2,699 | 2,741 | 2,698 | 2,737 | +51 | +1.9% | 258,600 |
2015/02/19 | 2,677 | 2,690 | 2,658 | 2,686 | +20 | +0.8% | 176,000 |
2015/02/18 | 2,650 | 2,678 | 2,626 | 2,666 | +45 | +1.7% | 289,800 |
2015/02/17 | 2,630 | 2,634 | 2,599 | 2,621 | -1 | ±0% | 156,800 |
2015/02/16 | 2,613 | 2,632 | 2,571 | 2,622 | +37 | +1.4% | 223,800 |
2451~
2500
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 148,800円 | +8.8% | +99.9% | 3.49% | 9.50倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 217,600円 | +3.1% | -6.5% | 2.21% | 10.10倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 309,500円 | +3.0% | +27.5% | 2.58% | 19.59倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 223,000円 | +0.4% | -8.4% | 2.38% | 28.63倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 87,600円 | +20.3% | - | 0.00% | 154.50倍 | 1.15倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム